Lantern Wealth Advisors, LLC Ab Cellera Biologics Inc. Transaction History
Lantern Wealth Advisors, LLC
- $189 Billion
- Q3 2025
A detailed history of Lantern Wealth Advisors, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Lantern Wealth Advisors, LLC holds 15,000 shares of ABCL stock, worth $55,350. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$55,350
Previous $51.5 Million
46.65%
% of portfolio
0.04%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ABCL
# of Institutions
170Shares Held
110MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$38.5 Million0.04% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...